-
INT J CLIN PRACT 2024 10.1155/2024/1805803
Outcomes of Tamoxifen Treatment Alone in Patients With Ductal Carcinoma In Situ or Atypical Ductal Hyperplasia Who Refused Surgery
Kwak, Y; Ryu, JM; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
JAMA NETW OPEN 2024 10.1001/jamanetworkopen.2024.42663
Age and Late Recurrence in Young Patients With ER-Positive, ERBB2-Negative Breast Cancer
Shin, DS; Lee, JH; Kang, E; Noh, D; Cheun, JH; Lee, JH; Son, Y; Bae, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Kwon, S; Lee, HB; Ahn, SG; Ryu, JM
View PubMed
-
CANCER-AM CANCER SOC 2024 10.1002/cncr.35567
Nonsentinel lymph node metastases in cases of micrometastasis detected by sentinel lymph node biopsy after neoadjuvant chemotherapy
Shin, DS; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
View PubMed
-
EJSO-EUR J SURG ONC 2024 10.1016/j.ejso.2024.108644
Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes
Park, WK; Kim, HJ; Ryu, JM; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
CANCERS 2024 10.3390/cancers16142566
The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer
Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Ryu, JM; Chae, B
View PubMed
-
NPJ BREAST CANCER 2024 10.1038/s41523-024-00669-9
Prognostic value of structural variants in early breast cancer patients
Kim, JY; Park, K; Park, WY; Ahn, JS; Im, YH; Lee, JE; Kim, SW; Nam, SJ; Yu, J; Park, YH
View PubMed
-
CANCERS 2024 10.3390/cancers16101865
The Effects of National Insurance Coverage Expansion and Genetic Counseling's Role on BRCA1/2 Mutation Tests in Breast Cancer Patients
Jang, SY; Kwak, Y; Choi, JY; Shin, DS; Lee, H; Kim, M; Jung, BY; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
View PubMed
-
NPJ PRECIS ONCOL 2024 10.1038/s41698-024-00559-0
Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations
Park, WK; Chung, SY; Jung, YJ; Ha, C; Kim, JW; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, JE; Kim, SW; Ryu, JM
View PubMed
-
BMC WOMENS HEALTH 2024 10.1186/s12905-024-02973-9
Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients
Kim, EY; Lee, KH; Yun, JS; Park, YL; Park, CH; Jang, SY; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, JH
View PubMed
-
BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01559-5
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile
Kang, DB; Park, S; Kim, HJ; Lee, JS; Han, JY; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Cho, JH; Park, YH
View PubMed
-
J BREAST CANCER 2024 10.4048/jbc.2023.0196
Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched Cohort
Shin, DS; Bang, YJ; Choi, JY; Jang, SY; Lee, H; Kwak, Y; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Jeon, BJ; Pyon, JK; Mun, GH; Lee, KT; Ryu, JM
View PubMed
-
BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01547-9
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants
Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H
View PubMed
-
CANCER RES TREAT 2024 10.4143/crt.2023.673
Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study
Kang, D; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Kim, JY; Nam, SJ; Cho, J; Park, YH
View PubMed
-
BREAST 2023 10.1016/j.breast.2023.103594
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer
Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
View PubMed
-
INT J MOL SCI 2023 10.3390/ijms242115576
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Jung, HH; Kim, JY; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
View PubMed
-
CANCERS 2023 10.3390/cancers15225361
The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer
Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ
View PubMed
-
CANCERS 2023 10.3390/cancers15225473
The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis
Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2023.1230310
Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study
Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
View PubMed
-
CANCERS 2023 10.3390/cancers15194720
Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer
Shin, J; Kim, JY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, W; Park, YH; Ahn, JS; Im, YH
View PubMed
-
WORLD J CLIN CASES 2023 10.12998/wjcc.v11.i27.6398
Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY
View PubMed
-
JMIR PUBLIC HLTH SUR 2023 10.2196/45212
Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis
Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK
View PubMed
-
THER ADV MED ONCOL 2023 10.1177/17588359231189421
Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study
Kang, DB; Cho, JH; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Park, YH
View PubMed
-
CANCERS 2023 10.3390/cancers15133435
Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study
Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
View PubMed
-
ANN SURG TREAT RES 2023 10.4174/astr.2023.105.1.10
Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study
Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
View PubMed
-
EXP MOL MED 2023 10.1038/s12276-023-01030-z
Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH
View PubMed
-
CANCERS 2023 10.3390/cancers15092646
Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer
Lee, H; Choi, JY; Park, YH; Lee, JE; Kim, SW; Nam, SJ; Cho, YS
View PubMed
-
J BREAST CANCER 2023 10.4048/jbc.2023.26.e11
Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study
Yeo, SM; Lim, JY; Kim, SW; Chae, BJ; Yu, JH; Ryu, JM; Hwang, JH
View PubMed
-
CANCERS 2023 10.3390/cancers15051556
Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis
Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J
View PubMed
-
BIOMEDICINES 2023 10.3390/biomedicines11030675
Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells
Kim, S; Kim, H; Jeong, Y; You, D; Yoon, SY; Lo, EJ; Nam, SJ; Lee, JE; Kim, SW
View PubMed
-
ANN SURG TREAT RES 2023 10.4174/astr.2023.104.3.137
The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection
Lee, J; Lee, JE; Ryu, JM; Kim, SW; Nam, SJ; Yu, JH
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2023.1039670
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial
Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW
View PubMed
-
J BREAST CANCER 2022 10.4048/jbc.2022.25.e49
Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay
Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW
View PubMed
-
ANN SURG ONCOL 2022 10.1245/s10434-022-12389-0
Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?
Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, J; Kim, SW; Lee, JE; Ryu, JM; Bang, SI
View PubMed
-
BREAST 2022 10.1016/j.breast.2022.09.004
Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy
Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
View PubMed
-
ANN SURG ONCOL 2022 10.1245/s10434-022-12602-0
ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter?
Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, JH; Kim, SW; Lee, JE; Ryu, JM; Bang, SI
View PubMed
-
J CLIN MED 2022 10.3390/jcm11216564
Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J
View PubMed
-
CANCER RES TREAT 2022 10.4143/crt.2021.901
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience
Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH
View PubMed
-
J BREAST CANCER 2022 10.4048/jbc.2022.25.e36
Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
View PubMed
-
CANCER RES TREAT 2022 10.4143/crt.2021.784
Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors
Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J
View PubMed
-
CANCER RES TREAT 2022 10.4143/crt.2021.791
Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE
View PubMed
-
FRONT ONCOL 2022 10.3389/fonc.2022.903372
Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy
Kim, JY; Oh, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kim, K; Im, YH
View PubMed
-
CURR ONCOL 2022 10.3390/curroncol29050267
Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea
Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE
View PubMed
-
J BREAST CANCER 2022 10.4048/jbc.2022.25.e17
Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society
Ryu, JM; Choi, HJ; Park, EH; Kim, JY; Lee, YJ; Park, S; Lee, J; Park, HK; Nam, SJ; Kim, SW; Lee, JH; Lee, JE
View PubMed
-
KOREAN J RADIOL 2022 10.3348/kjr.2020.1475
Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients
Kwon, MR; Ko, ES; Park, MS; Jeong, WK; Hwang, NY; Kim, JH; Lee, JE; Kim, SW; Yu, JH; Han, BK; Ko, EY; Choi, JS; Park, KW
View PubMed
-
VIRCHOWS ARCH 2022 10.1007/s00428-022-03280-0
Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations
Hwang, HW; Hong, SA; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
View PubMed
-
BREAST CANCER RES TR 2022 10.1007/s10549-021-06483-2
Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching
Kim, N; Kim, H; Park, W; Choi, DH; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Yu, J; Lee, SK; Jeon, BJ; Pyon, JK; Mun, GH; Kim, TG
View PubMed
-
CANCERS 2021 10.3390/cancers13215260
Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
Jung, HH; Kim, JY; Cho, EY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
View PubMed
-
J CLIN MED 2021 10.3390/jcm10204754
Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study
Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
View PubMed
-
BREAST CANCER RES TR 2021 10.1007/s10549-021-06309-1
Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea
Park, YH; Karantza, V; Calhoun, SR; Park, S; Lee, S; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Nam, SJ; Aktan, G; Marsico, M
View PubMed
-
J BREAST CANCER 2021 10.4048/jbc.2021.24.e30
Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial
Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW
View PubMed
-
J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e194
Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea
Rayzah, M; Ryu, JM; Lee, JH; Nam, SJ; Kim, SW; Lee, SK; Yu, J; Lee, KT; Bang, SI; Mun, GH; Pyon, JK; Jeon, BJ; Lee, JE
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-94195-4
Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients
Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
View PubMed
-
MOLECULES 2021 10.3390/molecules26123644
Entelon(R) (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells
You1, D; Jeong, Y; Yoon, SY; Kim, SA; Lo, E; Kim, SW; Lee, JE; Nam, SJ; Kim, S
View PubMed
-
FRONT ONCOL 2021 10.3389/fonc.2021.691277
Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea
Lee1, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
View PubMed
-
ONCOL REP 2021 10.3892/or.2021.8040
Celastrol attenuates the inflammatory response by inhibiting IL-1 beta expression in triple-negative breast cancer cells
You1, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE; Kim, S
View PubMed
-
FRONT ONCOL 2021 10.3389/fonc.2021.596364
Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry
Kim1, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH
View PubMed
-
BMC SURG 2021 10.1186/s12893-021-01129-y
The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial
Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW
View PubMed
-
EJSO-EUR J SURG ONC 2021 10.1016/j.ejso.2020.08.023
Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer
Woo1, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
View PubMed
-
J BREAST CANC 2021 10.4048/jbc.2021.24.e4
Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer
Min1, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ
View PubMed
-
FRONT ONCOL 2021 10.3389/fonc.2021.588728
Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer
Kwon1, MJ; Ryu, JM; Cho, SY; Nam, SJ; Kim, SW; Lee, J; Lee, SJ; Park, JY; Park, HY; Hong, S; Kim, K; Han, J; Moon, Y; Shin, YK; Lee, JE
View PubMed
-
BMC CANCER 2021 10.1186/s12885-020-07729-w
Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?
Jung1, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE
View PubMed
-
NAT COMMUN 2020 10.1038/s41467-020-19933-0
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
Park1, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z
View PubMed
-
JAMA SURG 2020 10.1001/jamasurg.2020.4124
Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence
Lee1, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI
View PubMed
-
INT J MOL SCI 2020 10.3390/ijms21228697
ANK2 Hypermethylation in Canine Mammary Tumors and Human Breast Cancer
Schabort1, JJ; Nam, AR; Lee, KH; Kim, SW; Lee, JE; Cho, JY
View PubMed
-
CYTOKINE 2020 10.1016/j.cyto.2020.155213
WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells
Kim1, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
ANN SURG TREAT RES 2020 10.4174/astr.2020.99.5.251
Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?
Jung1, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE
View PubMed
-
ASIA-PAC J CLIN ONCO 2020 10.1111/ajco.13444
Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer
Kim1, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY
View PubMed
-
MOL CANCER RES 2020 10.1158/1541-7786.MCR-19-1108
Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer
Park1, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH
View PubMed
-
NUTRIENTS 2020 10.3390/nu12092831
Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients
Kim1, JA; Choi, R; Won, H; Kim, S; Choi, HJ; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Lee, SY
View PubMed
-
J CLIN MED 2020 10.3390/jcm9092846
Impact of Serum Lipid on Breast Cancer Recurrence
Jung1, SM; Kang, D; Guallar, E; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Cho, J; Lee, SK
View PubMed
-
BREAST CANCER RES TR 2020 10.1007/s10549-020-05874-1
Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer
Kim1, JY; Jung, HH; Sohn, I; Woo, SY; Cho, H; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
View PubMed
-
ANN SURG TREAT RES 2020 10.4174/astr.2020.98.5.215
Surgical impact on anxiety of patients with breast cancer: 12-month follow-up prospective longitudinal study
Kim1, J; Cho, J; Lee, SK; Choi, EK; Kim, IR; Lee, JE; Kim, SW; Nam, SJ
View PubMed
-
J CLIN MED 2020 10.3390/jcm9041192
Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence
Ryu1, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK
View PubMed
-
JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147
Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors
Ryu1, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J
View PubMed
-
J BREAST CANC 2019 10.4048/jbc.2019.22.e48
Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm
Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
View PubMed
-
BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y
Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy
Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK
View PubMed
-
ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169
Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK
View PubMed
-
EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011
A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning
Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
ONCOL REP 2019 10.3892/or.2018.6910
TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells
Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
PLoS One 2019 10.1371/journal.pone.0212309
Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment
Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
View PubMed
-
BREAST CANCER RES TR 2019 10.1007/s10549-018-4947-z
Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?
Lee1, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ
View PubMed
-
HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3
The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY
View PubMed
-
NUTRIENTS 2019 10.3390/nu11010037
Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients
Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY
View PubMed
-
BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW
View PubMed
-
BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY
View PubMed
-
J BREAST CANC 2018 10.4048/jbc.2018.21.e54
Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
View PubMed
-
KAOHSIUNG J MED SCI 2018 10.1016/j.kjms.2018.07.003
Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer
Bae1, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ
View PubMed
-
BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y
Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer
Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW
View PubMed
-
J BREAST CANC 2018 10.4048/jbc.2018.21.e50
Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study
Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
View PubMed
-
PHYTOMEDICINE 2018 10.1016/j.phymed.2018.08.004
Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells
Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort
Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
View PubMed
-
CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010
Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment
Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S
View PubMed
-
ONCOLOGY-BASEL 2018 10.1159/000488944
Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype
Bae1, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
View PubMed
-
J BREAST CANC 2018 10.4048/jbc.2018.21.2.222
Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer
Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
View PubMed
-
J BREAST CANC 2018 10.4048/jbc.2018.21.2.173
Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer
Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
J BREAST CANC 2018 10.4048/jbc.2018.21.2.206
Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?
Cho1, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY
View PubMed
-
WORLD J SURG 2018 10.1007/s00268-017-4342-7
Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer
Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ
View PubMed
-
NAT COMMUN 2018 10.1038/s41467-018-04129-4
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
Kan1, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH
View PubMed
-
J BREAST CANC 2018 10.4048/jbc.2018.21.1.21
Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells
Jeong1, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S
View PubMed
-
J BREAST CANC 2018 10.4048/jbc.2018.21.1.91
Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy
Park1, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH
View PubMed
-
CELL PHYSIOL BIOCHEM 2018 10.1159/000487171
Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells
Kim1, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003
Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane
Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ
View PubMed
-
TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.002
Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast
Kim1, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE
View PubMed
-
BREAST CANCER RES TR 2017 10.1007/s10549-017-4472-5
Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society
Ryu1, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.22220
Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer
Woo1, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY
View PubMed
-
CLIN BREAST CANCER 2017 10.1016/j.clbc.2017.03.014
Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis
Ryu1, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.21198
Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy
Kim1, JY; Park, D; Son, DS; Nam, SJ; Kim, SW; Jung, HH; Kim, YJ; Park, G; Park, WY; Lee, JE; Park, YH
View PubMed
-
J BREAST CANC 2017 10.4048/jbc.2017.20.3.297
Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry
You1, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE
View PubMed
-
J BREAST CANC 2017 10.4048/jbc.2017.203.270
Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy
Kim1, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.10843
Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction
Jeon1, M; You, D; Bae, SY; Kim, SW; Nam, SJ; Kim, HH; Kim, S; Lee, JE
View PubMed
-
ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652
Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy
Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY
View PubMed
-
J Breast Cancer. 2017 Mar;20(1):74-81. doi: 10.4048/jbc.2017.20.1.74. Epub 2017 Mar 24.
Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study
Ryu JM11, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.
View PubMed
-
J Breast Cancer. 2017 Mar;20(1):91-97. doi: 10.4048/jbc.2017.20.1.91. Epub 2017 Mar 24.
Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy
Kim I11, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.
View PubMed
-
Clin Breast Cancer. 2017 Feb;17(1):e19-e29. doi: 10.1016/j.clbc.2016.06.020. Epub 2016 Jul 9.
Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer
Park S11, Lee JE2, Paik HJ1, Ryu JM1, Bae SY1, Lee SK1, Kim SW1, Nam SJ1.
View PubMed
-
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10(2):1738-1746
Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy
Yoon N1, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY
View PubMed
-
Medicine (Baltimore). 2017 Jan;96(1):e5746. doi: 10.1097/MD.0000000000005746.
Conditional disease-free survival among patients with breast cancer
Paik HJ11, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.
View PubMed
-
Breast Cancer Res Treat. 2017 Jan;161(1):95-102. doi: 10.1007/s10549-016-4034-2. Epub 2016 Oct 25.
Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
Kim H11, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.
View PubMed
-
Breast. 2016 Dec;30:111-117. doi: 10.1016/j.breast.2016.08.011. Epub 2016 Sep 30.
Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype
Alramadhan M11, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.
View PubMed
-
Cancer Res Treat. 2016 Oct;48(4):1382-1388. Epub 2016 Mar 11.
Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea
Kim HK11, Ham JS1, Byeon S1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Lee JY1, Lim SH1, Kim HS1, Kim JY1, Lee JE2, Kim SW2, Nam SJ2, Lee SK2, Bae SY2, Ahn JS1, Im YH1, Park YH1.
View PubMed
-
Breast Cancer Res Treat. 2016 Oct;159(3):489-98. doi: 10.1007/s10549-016-3943-4. Epub 2016 Sep 2.
Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society
Ryu JM11, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.
View PubMed
-
PLoS One. 2016 Sep 20;11(9):e0163254. doi: 10.1371/journal.pone.0163254. eCollection 2016.
Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series
Lee MY11, Chang WJ1, Kim HS1, Lee JY1, Lim SH1, Lee JE2, Kim SW2, Nam SJ2, Ahn JS1, Im YH1, Park YH1.
View PubMed
-
World J Surg. 2016 Aug;40(8):2028-35. doi: 10.1007/s00268-016-3487-0.
Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm
Ryu JM11, Nam SJ1, Kim SW1, Lee SK1, Bae SY1, Yi HW1, Park S1, Paik HJ1, Lee JE2.
View PubMed
-
SCIENTIFIC REPORTS, AUG 22 2016, 6, DOI: 10.1038/srep31804
The relationship between nuclear factor (NF)-kappa B family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment
Kim JY1, Jung HH, Ahn S, Bae S, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH
View PubMed
-
Cancer Res Treat. 2016 Jul;48(3):955-61. doi: 10.4143/crt.2015.191. Epub 2016 Jan 19.
Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer
Kim H11, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.
View PubMed
-
Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11.
Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes
Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
View PubMed
-
J Breast Cancer. 2016 Jun;19(2):169-75. doi: 10.4048/jbc.2016.19.2.169. Epub 2016 Jun 24.
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes
Kim SW11, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.
View PubMed
-
Genes Chromosomes Cancer. 2016 Jun;55(6):495-504. doi: 10.1002/gcc.22351. Epub 2016 Mar 3.
Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade
Yoon N11, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.
View PubMed
-
BMC Cancer. 2016 Feb 22;16:138. doi: 10.1186/s12885-016-2195-3.
Prognostic value of ERBB4 expression in patients with triple negative breast cancer
Kim JY11, Jung HH2, Do IG3, Bae S4, Lee SK5, Kim SW6, Lee JE7, Nam SJ8, Ahn JS9, Park YH10,11, Im YH12,13.
View PubMed
-
Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18.
Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments
Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
View PubMed
-
Oncotarget. 2015 Dec 22;6(41):43731-42. doi: 10.18632/oncotarget.6192.
Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer
Lee JY11, Park K2, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Hong M3, Do IG3, Ahn T2, Lee SK4, Bae SY4, Kim SW4, Lee JE4, Nam SJ4, Kim DH5, Jung HH6, Kim JY1, Ahn JS1, Im YH1, Park YH1.
View PubMed
-
J Breast Cancer. 2015 Dec;18(4):386-93. doi: 10.4048/jbc.2015.18.4.386. Epub 2015 Dec 23.
Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery
Lee JH11, Lee SK1, Park SM1, Ryu JM1, Paik HJ1, Yi HW1, Bae SY1, Lee JE1, Kim SW1, Nam SJ1.
View PubMed
-
Cancer Res Treat. 2015 Oct;47(4):765-73. doi: 10.4143/crt.2014.168. Epub 2015 Jan 13.
Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer
Lee JY11, Lim SH1, Lee MY1, Kim H1, Kim M1, Kim S1, Jung HA1, Sohn I2, Gil WH3, Lee JE3, Kim SW3, Nam SJ3, Ahn JS1, Im YH1, Park YH1.
View PubMed
-
Oncotarget. 2015 Sep 15;6(27):24499-510.
Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay
Park K11, Choi MK2, Jung HH3, Do IG4, Lee KH5, Ahn T1, Kil WH6, Kim SW6, Lee JE6, Nam SJ6, Kim DH7, Ahn JS2, Im YH2,3, Park YH2,3.
View PubMed
-
Fam Cancer. 2015 Sep;14(3):365-71. doi: 10.1007/s10689-015-9789-9.
Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation
Kim H11, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.
View PubMed
-
PLoS One. 2015 Aug 4;10(8):e0124658. doi: 10.1371/journal.pone.0124658. eCollection 2015.
Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival
Lee SK11, Bae SY1, Lee JH1, Lee HC1, Yi H1, Kil WH1, Lee JE1, Kim SW1, Nam SJ1.
View PubMed
-
Oncology. 2015;88(6):337-44. doi: 10.1159/000368985. Epub 2015 Feb 25.
Immediate Postoperative Inflammation Is an Important Prognostic Factor in Breast Cancer
Lee SK11, Choi MY, Bae SY, Lee JH, Lee HC, Kil WH, Lee JE, Kim SW, Nam SJ.
View PubMed
-
Int J Cancer. 2015 Apr 15;136(8):1976-84. doi: 10.1002/ijc.29233. Epub 2014 Dec 24.
A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery
Park YH11, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.
View PubMed
-
J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27.
Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer
Yu JI11, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.
View PubMed
-
BMC Cancer. 2015 Mar 18;15:138. doi: 10.1186/s12885-015-1121-4.
Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer
Bae SY11, Kim S2, Lee JH3, Lee HC4, Lee SK5, Kil WH6, Kim SW7, Lee JE8, Nam SJ9.
View PubMed
-
Surgery. 2015 Mar;157(3):518-25. doi: 10.1016/j.surg.2014.10.013. Epub 2014 Nov 6.
Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary A randomized, controlled study
Lee SK11, Lee JH1, Bae SY1, Kim J1, Kim M1, Lee HC1, Jung YY2, Kil WH1, Kim SW1, Lee JE1, Nam SJ1, Choe JH1, Kim JH1, Kim JS3.
View PubMed
-
J Breast Cancer. 2015 Mar;18(1):22-8. doi: 10.4048/jbc.2015.18.1.22. Epub 2015 Mar 27.
Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in Patients with Initial Cytology-Proven Axillary Node Metastasis
Kim JY11, Kim MK2, Lee JE3, Jung Y1, Bae SY3, Lee SK3, Kil WH3, Kim SW3, Kim KS4, Nam SJ3, Han S1.
View PubMed
-
Tumour Biol. 2015 Feb;36(2):1073-9. doi: 10.1007/s13277-014-2730-2. Epub 2014 Oct 19.
Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology
Jung HA11, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.
View PubMed
-
Hum Pathol. 2014 Dec;45(12):2480-7. doi: 10.1016/j.humpath.2014.08.015. Epub 2014 Sep 7.
Invasive Paget disease of the breast: 20 years of experience at a single institution
Lee HW11, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.
View PubMed
-
Oncol Rep. 2014 Dec;32(6):2666-72. doi: 10.3892/or.2014.3514. Epub 2014 Sep 24.
Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells
Kim S11, Kil WH1, Lee J1, Oh SJ1, Han J1, Jeon M1, Jung T1, Lee SK1, Bae SY1, Lee HC1, Lee JH1, Yi HW1, Kim SW1, Nam SJ1, Lee JE1.
View PubMed
-
Phytother Res. 2014 Nov;28(11):1654-60. doi: 10.1002/ptr.5178. Epub 2014 May 30.
Zerumbone Suppresses IL-1 beta-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells
Han J11, Bae SY, Oh SJ, Lee J, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Nam SJ, Kim S, Lee JE.
View PubMed
-
Breast. 2014 Oct;23(5):670-5. doi: 10.1016/j.breast.2014.07.005. Epub 2014 Jul 31.
Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy
Kim J11, Kim M2, Lee JH2, Lee H2, Lee SK2, Bae SY2, Jun SY3, Kil WH2, Lee JE4, Kim SW2, Nam SJ2.
View PubMed
-
World J Surg. 2014 May;38(5):1065-9. doi: 10.1007/s00268-014-2468-4.
The Protective Effect of Parity in Hormone Receptor-Positive, Ki-67 Expressing Breast Cancer
Lee SK11, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ.
View PubMed
-
J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28.
Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ
Lee JH11, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.
View PubMed
-
Oncol Rep. 2014 Mar;31(3):1423-8. doi: 10.3892/or.2013.2936. Epub 2013 Dec 19.
Protein kinase C- a downregulates estrogen receptor- a by suppressing c- Jun phosphorylation in estrogen receptor- positive breast cancer cells
Kim S11, Lee J1, Lee SK1, Bae SY1, Kim J1, Kim M1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.
View PubMed